EI
ETNB

EAM Investors’s 89bio ETNB Stock Holding History

EAM Investors’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-216,438
Closed -$4.1M – 312
2023
Q2 		$4.1M Sell
216,438
-69,982
-24% -$1.23M 0.76% 11
2023
Q1 		$4.36M Buy
286,420
+10,477
+4% +$137K 0.86% 9
2022
Q4 		$3.51M Buy
275,943
+85,225
+45% +$767K 0.73% 16
2022
Q3 		$1.1M Buy
+190,718
New +$838K 0.24% 185

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EAM Investors's ETNB Position: Q3 2023 in Review

EAM Investors sold out of 89bio (ETNB) in Q3 2023, closing a stake of 216,438 shares — an estimated $4.1M sold.

EAM Investors first reported a position in ETNB in Q3 2022 and held it in 4 quarters. The position peaked at $4.36M in Q1 2023. 160 funds tracked by Wall St. Rank hold ETNB as of Q3 2023.

  • EAM Investors reported no remaining 89bio position as of Q3 2023 after selling out during the quarter.
  • EAM Investors sold 216,438 89bio shares in Q3 2023, an estimated $4.1M.
  • EAM Investors first reported a position in 89bio in Q3 2022 and held it in 4 quarters.
  • EAM Investors's 89bio position peaked at $4.36M in Q1 2023.
  • 160 funds tracked by Wall St. Rank held 89bio as of Q3 2023.

Based on EAM Investors's 13F filing for Q3 2023, filed 13 Nov 2023.